Travere Therapeutics, Inc. (TVTX) Stock News & Chart | StockAdder

(TVTX)

Travere Therapeutics, Inc.

Stock chart and latest news for Travere Therapeutics, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Travere Therapeutics, Inc. News

PRO

Five new Travere hires get stock awards totaling 17,420 shares

Apr 14, 2026 GuruFocus

Travere Therapeutics (TVTX) Shares Surge 33% in Trading

Apr 15, 2026 Investing.com

Travere Therapeutics stock hits 52-week high at 42.2 USD

Apr 14, 2026 MEXC

Travere Therapeutics (TVTX) Stock Rockets 44% on Groundbreaking FSGS Treatment Approval

Apr 14, 2026 timothysykes.com

TVTX Stock Jumps As FILSPARI Wins Full FDA Approval

Apr 14, 2026 TipRanks

This Is Why Travere Therapeutics Stock (TVTX) Surged Today

Apr 14, 2026 Benzinga

Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday

Apr 14, 2026 Stock Traders Daily

How Travere Therapeutics Inc. (TVTX) Affects Rotational Strategy Timing

Apr 13, 2026 StocksToTrade

TVTX Stock Jumps As FDA Approval Fuels Bullish Momentum

Apr 14, 2026 Stock Titan

Elizabeth Reed reports sales of TVTX common stock (NASDAQ: TVTX) in Form 144

Apr 15, 2026 GuruFocus

Travere Therapeutics (TVTX) Surges 32.5% in Market Performance

Apr 14, 2026 Stock Titan

TVTX (NASDAQ: TVTX) files Form 144 to resell 7,215 RSU shares